---
figid: PMC5418445__bjc201769f1
figlink: /pmc/articles/PMC5418445/figure/fig1/
number: Figure 1
caption: 'Tumour angiogenesis: molecular pathways and potential interventional strategies.
  VEGF axis is recognised as the primary factor responsible for tumour angiogenesis
  resistance. Upon VEGF binding, the receptor tyrosine is activated. VEGF/VEGFR activates
  oncogenic signalling via mitogen-activated protein kinase (ERK/MAPK) pathway, the
  phosphotidylinositol 3 kinase (PI3K-AKT) pathway, and the phospholipase-C-γ (PLC-γ)
  pathway leading to cell proliferation, survival, migration, and vascular permeability.
  Chronic VEGF/VEGFR inhibition has been found to lead to the emergence of compensatory
  signalling pathways that sustain angiogenesis. Several of these VEGF-independent
  signalling pathways, rely on key proteins, including the FGF/FGFR, angiopoietin-2
  (Ang2), and the MET oncogene. Complementary therapies focused on these alternative
  pathways have been developed to abrogate acquired resistance. Pan-FGFR inhibitors
  are used to inhibit the FGF/FGFR axis. The MET/HGF pathway is inhibited by HGF antagonists
  and by the anti-MET antibody cabozantinib. Ang-Tie axis can be targeted with trebananib,
  a peptibody that inhibits the binding of Ang1/2 to their receptor. Tumour microenvironment
  and interactions between tumour cells and non-malignant cells as fibroblast and
  leukocytes also affect angiogenesis by interfering with the signalling pathways
  required for cell recruitment and vascular construction.'
pmcid: PMC5418445
papertitle: 'Personalising and targeting antiangiogenic resistance: a complex and
  multifactorial approach.'
reftext: Maria J Bueno, et al. Br J Cancer. 2017 Apr 25;116(9):1119-1125.
pmc_ranked_result_index: '33190'
pathway_score: 0.8928795
filename: bjc201769f1.jpg
figtitle: 'Tumour angiogenesis: molecular pathways and potential interventional strategies'
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5418445__bjc201769f1.html
  '@type': Dataset
  description: 'Tumour angiogenesis: molecular pathways and potential interventional
    strategies. VEGF axis is recognised as the primary factor responsible for tumour
    angiogenesis resistance. Upon VEGF binding, the receptor tyrosine is activated.
    VEGF/VEGFR activates oncogenic signalling via mitogen-activated protein kinase
    (ERK/MAPK) pathway, the phosphotidylinositol 3 kinase (PI3K-AKT) pathway, and
    the phospholipase-C-γ (PLC-γ) pathway leading to cell proliferation, survival,
    migration, and vascular permeability. Chronic VEGF/VEGFR inhibition has been found
    to lead to the emergence of compensatory signalling pathways that sustain angiogenesis.
    Several of these VEGF-independent signalling pathways, rely on key proteins, including
    the FGF/FGFR, angiopoietin-2 (Ang2), and the MET oncogene. Complementary therapies
    focused on these alternative pathways have been developed to abrogate acquired
    resistance. Pan-FGFR inhibitors are used to inhibit the FGF/FGFR axis. The MET/HGF
    pathway is inhibited by HGF antagonists and by the anti-MET antibody cabozantinib.
    Ang-Tie axis can be targeted with trebananib, a peptibody that inhibits the binding
    of Ang1/2 to their receptor. Tumour microenvironment and interactions between
    tumour cells and non-malignant cells as fibroblast and leukocytes also affect
    angiogenesis by interfering with the signalling pathways required for cell recruitment
    and vascular construction.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - MAPK3
  - MAPK13
  - MAPK8
  - MAPK11
  - FGF13
  - FGF4
  - MAPK9
  - FGF12
  - PIK3CG
  - FGF5
  - MAPK14
  - AKT3
  - MAPK10
  - AKT2
  - AKT1
  - MET
  - MAPK12
  - PIK3R4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3R3
  - VEGFA
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF16
  - FGF1
  - FGF2
  - FGF3
  - RHOD
  - TEK
  - VEGFD
  - PGF
  - FGF23
  - FGF18
  - FGF17
  - FGF19
  - FGFRL1
  - FGF10
  - FGF11
  - FGFR3
  - FGFR1
  - FGF14
  - FGF20
  - FGF21
  - FGF22
  - FLT1
  - FGFR4
  - VEGFB
  - VEGFC
  - PIK3R5
  - HGF
  - FGFR2
  - PIK3R6
  - PLCG2
  - RAC1
  - FLT4
  - KDR
  - PLCG1
  - Nintedanib
  - Lenvatinib
  - Cabozantinib
  - Cancer
genes:
- word: ERK/MAPK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK/MAPK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: c-MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: ERK/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: VEGF-dependent
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: Rac1/Rho
  symbol: Rho
  source: hgnc_alias_symbol
  hgnc_symbol: RHOD
  entrez: '29984'
- word: Tie2
  symbol: TIE-2
  source: hgnc_alias_symbol
  hgnc_symbol: TEK
  entrez: '7010'
- word: VEGF-dependent
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF-dependent
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: VEGF-dependent
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF-dependent
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: Rac1/Rho
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
chemicals:
- word: Nintedanib
  source: MESH
  identifier: C530716
- word: Lenvatinib
  source: MESH
  identifier: C531958
- word: Cabozantinib
  source: MESH
  identifier: C558660
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
